Hiroyuki Nakayama Selected Research

1,2-bis(2-pyridyl)ethylene

4/2008

Relationship between GST Yp induction and hepatocyte proliferation in rats treated with phase II drug metabolizing enzyme inducers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Nakayama Research Topics

Disease

40	Neoplasms (Cancer) 02/2022 - 07/2002
20	Inflammation (Inflammations) 11/2020 - 11/2006
14	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 12/2005
12	Hypertrophy 03/2017 - 01/2002
11	Cognitive Dysfunction 07/2022 - 01/2017
11	Heart Failure 11/2021 - 02/2004
11	Fibrosis (Cirrhosis) 01/2019 - 08/2003
11	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2002
9	Parkinson Disease (Parkinson's Disease) 10/2018 - 09/2006
7	Dementia (Dementias) 07/2022 - 01/2017
7	Amyloid Plaque 01/2021 - 03/2002
7	Carcinoma (Carcinomatosis) 09/2020 - 06/2012
6	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2017
6	Infections 01/2016 - 01/2002
5	Tauopathies 07/2022 - 10/2018
5	Adenocarcinoma 09/2020 - 01/2018
5	Stomach Neoplasms (Stomach Cancer) 12/2019 - 02/2012
4	Histiocytic Sarcoma 08/2021 - 12/2003
4	Cysts 01/2019 - 01/2013
3	Carcinogenesis 01/2021 - 09/2019
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2012
3	Neoplasm Metastasis (Metastasis) 05/2020 - 02/2012
3	Infarction (Infarctions) 01/2019 - 09/2012
3	Ischemia 01/2017 - 01/2011
3	Myocarditis (Carditis) 01/2016 - 09/2011
3	Cardiomyopathies (Cardiomyopathy) 05/2012 - 08/2006
3	Necrosis 06/2009 - 09/2007
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 02/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Lymphatic Metastasis 01/2021 - 06/2012
2	Metaplasia 05/2020 - 01/2020
2	Hyperplasia 01/2020 - 07/2018
2	Adenoma (Adenomas) 01/2020 - 01/2018
2	Lymphoma (Lymphomas) 07/2019 - 11/2017
2	Myocardial Infarction 01/2019 - 09/2012
2	Amyloidosis 02/2018 - 08/2008
2	Polyps 01/2018 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2011
2	Spinal Cord Diseases 11/2017 - 10/2011
2	Muscular Diseases (Myopathy) 11/2017 - 08/2006
2	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2017 - 11/2010
2	Neuroinflammatory Diseases 01/2017 - 05/2013

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
13	Amyloid (Amyloid Fibrils)IBA 07/2022 - 04/2012
9	CalciumIBA 01/2022 - 01/2003
8	Peptides (Polypeptides)IBA 07/2022 - 01/2018
7	AcidsIBA 11/2020 - 08/2008
6	Keratins (Keratin)IBA 01/2021 - 08/2011
5	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 05/2002
5	CytokinesIBA 01/2019 - 01/2011
5	AntigensIBA 12/2018 - 07/2002
5	LipidsIBA 01/2018 - 07/2007
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2015 - 09/2006
5	NF-kappa B (NF-kB)IBA 06/2012 - 01/2002
4	Formaldehyde (Formol)FDA Link 11/2020 - 05/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2002
4	Phosphotransferases (Kinase)IBA 01/2018 - 06/2003
4	VimentinIBA 10/2017 - 02/2012
4	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2017 - 01/2002
4	Angiotensin IIIBA 01/2016 - 01/2002
3	DipeptidesIBA 07/2022 - 01/2019
3	Tryptophan (L-Tryptophan)FDA Link 07/2022 - 01/2019
3	Cadherins (E-Cadherin)IBA 06/2022 - 06/2014
3	SynucleinsIBA 10/2021 - 10/2018
3	MucinsIBA 01/2021 - 07/2018
3	Toll-Like Receptor 9IBA 06/2019 - 04/2014
3	Mitochondrial DNA (mtDNA)IBA 01/2018 - 05/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 09/2011
3	Muramidase (Lysozyme)IBA 05/2016 - 12/2003
3	CalcineurinIBA 04/2013 - 08/2006
3	TubulinIBA 02/2012 - 09/2010
3	Protein Isoforms (Isoforms)IBA 01/2012 - 04/2003
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2010 - 09/2007
3	MAP Kinase Kinase Kinase 5IBA 12/2003 - 01/2002
2	Tyrosine (L-Tyrosine)FDA Link 07/2022 - 06/2019
2	tau Proteins (tau Protein)IBA 07/2022 - 01/2012
2	SynaptophysinIBA 01/2021 - 01/2019
2	ParaffinIBA 11/2020 - 11/2017
2	beta CateninIBA 09/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 05/2020 - 02/2016
2	Biological ProductsIBA 04/2020 - 01/2018
2	Keratin-19 (Keratin 19)IBA 01/2020 - 06/2017
2	Periodic AcidIBA 01/2020 - 06/2017
2	Protein AggregatesIBA 01/2020 - 10/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2019 - 07/2013
2	Prednisolone (Predate)FDA LinkGeneric 07/2019 - 08/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 06/2004
2	LigandsIBA 01/2019 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 02/2012
2	AntibodiesIBA 11/2018 - 01/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 06/2015
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018 - 04/2013
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018 - 03/2017
2	NestinIBA 06/2017 - 02/2012
2	NAD (NADH)IBA 01/2017 - 11/2010
2	phospholambanIBA 01/2017 - 05/2003
2	Pharmaceutical PreparationsIBA 12/2016 - 04/2008

Therapy/Procedure

10	Therapeutics 05/2020 - 06/2009
6	Drug Therapy (Chemotherapy) 01/2020 - 02/2012
3	Hepatectomy 08/2016 - 11/2007